TY - JOUR
T1 - Fungal infections - An overview
AU - Schellack, Natalie
AU - Du Toit, Jade
AU - Mokoena, Tumelo
AU - Bronkhorst, Elmien
N1 - Publisher Copyright:
© Medpharm
PY - 2019
Y1 - 2019
N2 - Fungi normally originate from the environment that surrounds us, and appear to be harmless until inhaled or ingestion of spores occurs. A pathogenic fungus may lead to infection. People who are at risk of acquiring fungal infection are those living with human immunodeficiency virus (HIV), cancer, receiving immunosuppressant therapy, neonates and those of advanced age. The management of superficial fungal infections is mainly topical, with agents including terbinafine, miconazole and ketoconazole. Oral treatment includes griseofulvin and fluconazole. Invasive fungal infections are difficult to treat, and are managed with agents including the azoles, echinocandins and amphotericin B. This paper provides a general overview of the management of fungus infections.
AB - Fungi normally originate from the environment that surrounds us, and appear to be harmless until inhaled or ingestion of spores occurs. A pathogenic fungus may lead to infection. People who are at risk of acquiring fungal infection are those living with human immunodeficiency virus (HIV), cancer, receiving immunosuppressant therapy, neonates and those of advanced age. The management of superficial fungal infections is mainly topical, with agents including terbinafine, miconazole and ketoconazole. Oral treatment includes griseofulvin and fluconazole. Invasive fungal infections are difficult to treat, and are managed with agents including the azoles, echinocandins and amphotericin B. This paper provides a general overview of the management of fungus infections.
UR - http://www.scopus.com/inward/record.url?scp=85063753663&partnerID=8YFLogxK
M3 - Review article
AN - SCOPUS:85063753663
SN - 1015-1362
VL - 86
SP - 33
EP - 40
JO - SA Pharmaceutical Journal
JF - SA Pharmaceutical Journal
IS - 1
ER -